MARKET

MEOBF

MEOBF

Mesoblast
OTCPK
1.530
NaN%
Closed 09:30 11/20 EST
OPEN
--
PREV CLOSE
1.530
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.900
52 WEEK LOW
1.140
MARKET CAP
1.99B
P/E (TTM)
-34.4595
1D
5D
1M
3M
1Y
5Y
1D
Mesoblast Receives Deloitte Leadership & Enterprise Growth Award
TipRanks · 2d ago
Mesoblast Showcased at ASX Investor Day
TipRanks · 6d ago
Mesoblast Investor Day Presentation Includes Risk Disclosures
TipRanks · 6d ago
Mesoblast Notice Discloses Director’s Indirect Shareholding
TipRanks · 11/13 06:18
Mesoblast Reports All Annual Meeting Resolutions Carried
TipRanks · 11/10 06:28
Mesoblast Reports RYONCIL Sales as Company Shifts Toward Commercial Execution
TipRanks · 11/09 23:08
Mesoblast Expands Management for Rexlemestrocel-L Programs
TipRanks · 11/09 23:07
Mesoblast Reports William Burns’ Final Director Interest Notice
TipRanks · 11/09 23:05
More
About MEOBF
Mesoblast Limited is an Australia-based biotechnology company. The Company is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has developing a range of late-stage product candidates, derived from its first and second generation proprietary mesenchymal lineage cell therapy technology platforms therapies for distinct indications. The Company's Ryoncil (remestemcel-L-rknd) is an allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy. Its other product candidate is Revascor (rexlemestrocel-L). Rexlemestrocel-L is second generation mesenchymal lineage precursor cell product platform and is in late-stage development for treatment of: Chronic heart failure (CHF) and Chronic low back pain (CLBP) due to degenerative disc disease. The two products have been commercialized in Japan and Europe by the Company's licensees.

Webull offers Mesoblast Ltd stock information, including OTCPK: MEOBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEOBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEOBF stock methods without spending real money on the virtual paper trading platform.